Zhu; Liangjin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhu; Liangjin.The latest application filed is for "sustained release formulation of a non-steroidal anti-inflammatory drug".

Company Profile

5.10.9

Zhu; Liangjin - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,729,651 - Garcia , et al.	2020-08-04
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,675,245 - Garcia , et al.	2020-06-09
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,617,642 - Garcia , et al.	2020-04-14
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,610,486 - Garcia , et al.	2020-04-07
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 10,123,974 - Garcia , et al. November 13, 2	2018-11-13
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent Grant 10,028,911 - Garcia , et al. July 24, 2	2018-07-24
Sustained release formulation of a non-steroidal anti-inflammatory drug Grant 9,974,744 - Garcia , et al. May 22, 2	2018-05-22
Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent Grant 9,770,414 - Garcia , et al. September 26, 2	2017-09-26
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130209547 - Garcia; Louie Daniel ; et al.	2013-08-15
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130209548 - Garcia; Louie Daniel ; et al.	2013-08-15
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130189350 - Garcia; Louie Daniel ; et al.	2013-07-25
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130189348 - Garcia; Louie Daniel ; et al.	2013-07-25
Sustained Release Formulation Of Methotrexate As A Disease-modifying Antirheumatic Drug (dmard) And An Anti-cancer Agent App 20130183370 - Garcia; Louie Daniel ; et al.	2013-07-18
Sustained Release Formulation Of Methotrexate As A Disease-modifying Antirheumatic Drug (dmard) And An Anti-cancer Agent App 20130183371 - Garcia; Louie Daniel ; et al.	2013-07-18
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20130183374 - Garcia; Louie Daniel ; et al.	2013-07-18
Sustained Release Formulation Of A Non-steroidal Anti-inflammatory Drug App 20120114740 - Garcia; Louie Daniel ; et al.	2012-05-10
Sustained Release Formulation Of Methotrexate As A Disease-modifying Antirheumatic Drug (dmard) And An Anti-cancer Agent App 20110280932 - Garcia; Louie Daniel ; et al.	2011-11-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.